Tricuspid atresia primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Overview
Effective measures for the primary prevention of tricuspid atresia as prenatal screening include fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness, fetal echocardiography between 18-22 weeks of pregnancy
Primary prevention
Primary prevention
- Effective measures for the primary prevention of tricuspid atresia as prenatal screening include:[1]
- Fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness.
- Fetal echocardiography between 18-22 weeks of pregnancy
References
References
- ↑ Galindo, A.; Comas, C.; Martínez, J. M.; Gutiérrez-Larraya, F.; Carrera, J. M.; Puerto, B.; Borrell, A.; Mortera, C.; de la Fuente, P. (2009). “Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation”. The Journal of Maternal-Fetal & Neonatal Medicine. 13 (3): 163–170. doi:10.1080/jmf.13.3.163.170. ISSN 1476-7058.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH